Newly Released OpenClinica 3.1 Will be Demonstrated at the Drug Information Association Annual Meeting
OpenClinica, LLC is pleased to announce the production release of OpenClinica 3.1, the culmination of 18 months of effort for the growing open source electronic data capture software company. OpenClinica enhances the productivity of clinical trials through highly capable, flexible, commercial open source software. The software is freely available for download at https://community.openclinica.com.
“OpenClinica 3.1 is the most capable, easy to use, and flexible release to date,” said Cal Collins, OpenClinica’s CEO. “The software improves the efficiency of data managers, monitors, and site users to capture and clean data, provides a way to easily customize data extract formats, includes an expanded web services interface to facilitate interoperability with other systems and data sources, and supports dynamic skip logic in case report forms. Both the Enterprise and Community editions of the software have been heavily tested at OpenClinica and by beta users in the open source community over the past six months, and we are pleased to release the technology for general production use.”
OpenClinica will hold demonstrations of the new software and answer questions at the Drug Information Association’s 47th Annual Meeting this month in Chicago (booth #1843), which kicks-off on June 19th.
Sound technology and a model that makes it easy to both adopt and adapt has propelled the growth of OpenClinica. Earlier this month, the company released statistics showing that over the last year, the number of clinical trials powered by OpenClinica grew by 250 percent. Collins says there are over 400 active production implementations worldwide and a single implementation can support multiple trials.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
